Disclosures for "Pediatric Influenza-Related Acute Necrotizing Encephalopathy in the United States: A Multicenter Retrospective Analysis "
-
Dr. Silverman has nothing to disclose.
-
Dr. Walsh has nothing to disclose.
-
Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
-
Dr. Thomas has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Fisher has nothing to disclose.
-
Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
-
Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
-
Derek Neilson has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Sharp has nothing to disclose.
-
Dr. Edelman has nothing to disclose.
-
Dr. Otallah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck.
-
Mrs. Morgan has nothing to disclose.
-
Dr. Grzezulkowska has nothing to disclose.
-
Mr. Nguyen has nothing to disclose.
-
Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sutton Pierce. Dr. Rao has stock in Epygenix, Inc. The institution of Dr. Rao has received research support from UCB. The institution of Dr. Rao has received research support from Eisai.
-
Shaina Hecht, MD has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Wharton has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
-
Dr. LaRocca has nothing to disclose.
-
Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
-
Dr. Wilson-Murphy has nothing to disclose.